These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25544148)

  • 1. [Lower limb edema during valpromide treatment: case report and literature review].
    Gabriel L; Darcissac C; Goutelle S; Sève P; Vial T; de La Gastine B
    Rev Med Interne; 2015 Oct; 36(10):698-700. PubMed ID: 25544148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe oedema after valproate and valpromide].
    Galland MC; Nguyen N; Alla P; Ruiz JM; Rodor F; Valli M
    Therapie; 2002; 57(2):194-6. PubMed ID: 12185971
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of valpromide.
    Bialer M
    Clin Pharmacokinet; 1991 Feb; 20(2):114-22. PubMed ID: 2029804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute pancreatitis induced by valproic acid].
    Jomli R; Nacef F; Douki S
    Encephale; 2013 Sep; 39(4):292-5. PubMed ID: 23541917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valpromide increases amplitude of heart rate circadian rhythm in remitted bipolar and unipolar disorders. A placebo-controlled study.
    Lemoine P; Fondarai J; Faivre T
    Eur Psychiatry; 2000 Nov; 15(7):424-32. PubMed ID: 11112935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of valpromide in psychiatric therapeutics].
    Lambert PA; Venaud G
    Encephale; 1987; 13(6):367-73. PubMed ID: 3131112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brief history of the development of valproate in bipolar disorders].
    Lempérière T
    Encephale; 2001; 27(4):365-72. PubMed ID: 11686059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium valproate-induced pedal edema on chronic therapy: A rare adverse drug reaction.
    Prajapati H; Kansal D; Negi R
    Indian J Pharmacol; 2017; 49(5):399-400. PubMed ID: 29515282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus-like syndrome and vasculitis induced by valpromide.
    Bonnet F; Morlat P; De Witte S; Combe C; Beylot J
    J Rheumatol; 2003 Jan; 30(1):208-9. PubMed ID: 12508420
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of endogenous depressions with valpromide (open study).
    Svestka J; Rysánek R; Cesková E
    Homeost Health Dis; 1991; 33(5-6):291-2. PubMed ID: 18265503
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed toxicity following acute ingestion of valpromide.
    Payen C; Frantz P; Martin O; Parant F; Moulsma M; Pulce C; Descotes J
    Hum Exp Toxicol; 2004 Mar; 23(3):145-8. PubMed ID: 15119534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase].
    Bourrier P; Varache N; Alquier P; Rabier D; Kamoun P; Lorre G; Alhayek G
    Presse Med; 1988 Nov; 17(39):2063-6. PubMed ID: 2974563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium Valproate-Induced Bilateral Pitting Pedal Edema - A Case Report.
    Panchal R; Chaudhary D; Anovadiya A
    Curr Drug Saf; 2018; 13(2):128-130. PubMed ID: 28782477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valpromide-amitriptyline interaction. Increase in the bioavailability of amitriptyline and nortriptyline caused by valpromide].
    Bertschy G; Vandel S; Jounet JM; Allers G
    Encephale; 1990; 16(1):43-5. PubMed ID: 2109680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
    Vandel S; Bertschy G; Jounet JM; Allers G
    Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.
    Bialer M; Rubinstein A; Raz I; Abramsky O
    Eur J Clin Pharmacol; 1984; 27(4):501-3. PubMed ID: 6440792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
    Pacifici GM; Temellini A; Giuliani L; Rane A; Thomas H; Oesch F
    Arch Toxicol; 1989; 63(2):157-9. PubMed ID: 2499297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of valpromide in dogs after various modes of administration.
    Bialer M; Rubinstein A
    Biopharm Drug Dispos; 1984; 5(2):177-83. PubMed ID: 6430363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.